Legend Biotech (LEGN) Return on Sales: 2020-2025
Historic Return on Sales for Legend Biotech (LEGN) over the last 6 years, with Sep 2025 value amounting to -0.34%.
- Legend Biotech's Return on Sales rose 43.00% to -0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.34%, marking a year-over-year increase of 43.00%. This contributed to the annual value of -0.28% for FY2024, which is 154.00% up from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Return on Sales is -0.34%, which was up 36.04% from -0.53% recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Return on Sales ranged from a high of -0.16% in Q3 2023 and a low of -6.75% during Q3 2022.
- In the last 3 years, Legend Biotech's Return on Sales had a median value of -0.76% in 2024 and averaged -1.45%.
- Its Return on Sales has fluctuated over the past 5 years, first slumped by 376bps in 2022, then spiked by 659bps in 2023.
- Quarterly analysis of 5 years shows Legend Biotech's Return on Sales stood at -3.35% in 2021, then crashed by 46bps to -3.81% in 2022, then skyrocketed by 130bps to -2.52% in 2023, then spiked by 212bps to -0.40% in 2024, then skyrocketed by 43bps to -0.34% in 2025.
- Its Return on Sales stands at -0.34% for Q3 2025, versus -0.53% for Q2 2025 and -0.40% for Q1 2025.